Culturally targeted messaging to increase HPV vaccination for daughters in Flint
Official title: Culturally Targeted Messaging and Parental Receptivity to the Human Papillomavirus Vaccine
Run by Michigan State University · NCT07301905 · Data updated 2026-11-12
This project will test whether culturally targeted messages help African American parents in Flint be more willing to vaccinate their vaccine-age daughters against HPV.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 265 (estimated) |
| Sponsor | Michigan State University Academic / other |
| Locations | 1 site (Flint, Michigan) |
| Status | Recruiting |
| Started | November 17, 2024 |
| Main results expected | June 2028 |
| Study ends | December 2028 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07301905 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Black/African American or White parents in Flint who have at least one daughter aged 8–17 who has not received any doses of the HPV vaccine.
✕Probably not a fit
Parents whose daughters have already started the HPV vaccine series, who do not identify as Black/African American or White, or who cannot participate in the Flint-based protocol are unlikely to benefit from this effort.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares culturally targeted HPV vaccine messages, general education-only messages, and no messaging to see which approach increases parents' intentions to vaccinate their daughters. Parents will view one of the message types and immediately report their vaccination intentions, and researchers will follow up six months later to record whether HPV vaccination was initiated. The study also measures activation of racism-related thinking and medical mistrust to understand how these factors influence message effectiveness. Messages were developed in collaboration with community members and a local health educator to reflect local cultural context.
Why it matters
Potential benefit: If successful, culturally targeted messaging could increase HPV vaccine uptake among African American girls and help reduce cervical cancer disparities.
How similar studies have gone: Previous work on culturally tailored vaccine messaging has sometimes improved vaccine intentions and uptake in minority groups, but results have been mixed and often depend on local context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Identify as Black/African American or White/Caucasian * Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine Exclusion Criteria: * N/A
Where it's running
-
Flint Journal Building
Flint, Michigan, United States Recruiting
Study contacts
- Study coordinator: Olivia Aspiras, PhD
- Email: aspiraso@msu.edu
- Phone: 810-600-9181
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microvideos to help HPV vaccination for childhood cancer survivors
This study tests whether short microvideos can help young adult survivors of childhood cancer decide to get the HPV vaccine, focusing on those in rural Utah who haven’t completed all HPV doses yet.
-
HPV prevention support for U.S. Vietnamese families
This pilot tests four digital components to help U.S. Vietnamese parents decide to vaccinate their adolescents against HPV.
-
How videos for Vietnamese American moms may help vaccinate their kids against HPV
This study tests whether short, mother-made videos about the HPV vaccine can help Vietnamese American moms decide to vaccinate their children aged 11-14.
-
Combining HPV vaccination with adolescent health services in Ivory Coast
This study is trying to see if combining HPV vaccinations with regular health services can help more young people in Ivory Coast get vaccinated.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.